1 suspended. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Suspended 1 |
Follow Scleroderma, Diffuse: new trials by email Literature Review of Scleroderma, Diffuse trials Research Report on Scleroderma, Diffuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic Sclerosis Patients will be randomized to receive EHP-101 or Placebo - Diffuse Cutaneous Systemic Sclerosis | Phase 2 | Suspended | Emerald Health Pharmaceuticals | 36 | 2020-06-11 | 2023-09-21 |
Connective Tissue Diseases (1) · Pathologic Processes (1) · Scleroderma, Systemic (1) · Skin Diseases (1)
Pathological Conditions, Signs and Symptoms (1) · Skin and Connective Tissue Diseases (1)
Emerald Health Pharmaceuticals (1)
Australia (1) · New Zealand (1) · Puerto Rico (1) · United States (1)